NBIX logo

Neurocrine Biosciences (NBIX) Retained earnings

annual retained earnings:

$29.20M+$186.30M(+118.59%)
December 31, 2024

Summary

  • As of today (May 31, 2025), NBIX annual retained earnings is $29.20 million, with the most recent change of +$186.30 million (+118.59%) on December 31, 2024.
  • During the last 3 years, NBIX annual retained earnings has risen by +$665.00 million (+104.59%).
  • NBIX annual retained earnings is now at all-time high.

Performance

NBIX Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

quarterly retained earnings:

-$5.30M-$34.50M(-118.15%)
March 31, 2025

Summary

  • As of today (May 31, 2025), NBIX quarterly retained earnings is -$5.30 million, with the most recent change of -$34.50 million (-118.15%) on March 31, 2025.
  • Over the past year, NBIX quarterly retained earnings has increased by +$108.40 million (+95.34%).
  • NBIX quarterly retained earnings is now -106.54% below its all-time high of $81.10 million, reached on September 30, 2024.

Performance

NBIX quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

NBIX Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+118.6%+95.3%
3 y3 years+104.6%+99.0%
5 y5 years+102.6%+99.5%

NBIX Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+104.6%-106.5%+99.1%
5 y5-yearat high+102.6%-106.5%+99.5%
alltimeall timeat high+102.4%-106.5%+99.6%

NBIX Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$5.30M(-118.2%)
Dec 2024
$29.20M(-118.6%)
$29.20M(-64.0%)
Sep 2024
-
$81.10M(-266.5%)
Jun 2024
-
-$48.70M(-57.2%)
Mar 2024
-
-$113.70M(-27.6%)
Dec 2023
-$157.10M(-61.4%)
-$157.10M(-48.5%)
Sep 2023
-
-$304.80M(-21.4%)
Jun 2023
-
-$387.90M(-19.8%)
Mar 2023
-
-$483.40M(+18.8%)
Dec 2022
-$406.80M(-36.0%)
-$406.80M(-18.0%)
Sep 2022
-
-$495.80M(-12.1%)
Jun 2022
-
-$564.30M(+3.1%)
Mar 2022
-
-$547.40M(-13.9%)
Dec 2021
-$635.80M(-12.4%)
-$635.80M(+1.2%)
Sep 2021
-
-$628.50M(-3.5%)
Jun 2021
-
-$651.00M(-6.1%)
Mar 2021
-
-$693.30M(-4.4%)
Dec 2020
-$725.40M(-36.0%)
-$725.40M(-32.4%)
Sep 2020
-
-$1.07B(+5.7%)
Jun 2020
-
-$1.02B(-7.3%)
Mar 2020
-
-$1.10B(-3.3%)
Dec 2019
-$1.13B(-3.8%)
-$1.13B(-2.9%)
Sep 2019
-
-$1.17B(-4.4%)
Jun 2019
-
-$1.22B(-4.0%)
Mar 2019
-
-$1.27B(+8.0%)
Dec 2018
-$1.18B(-1.8%)
-$1.18B(-1.5%)
Sep 2018
-
-$1.20B(-4.1%)
Jun 2018
-
-$1.25B(+0.5%)
Mar 2018
-
-$1.24B(+3.5%)
Dec 2017
-$1.20B(+13.5%)
-$1.20B(-0.6%)
Sep 2017
-
-$1.21B(+0.9%)
Jun 2017
-
-$1.19B(+5.3%)
Mar 2017
-
-$1.13B(+7.4%)
Dec 2016
-$1.06B(+15.4%)
-$1.06B(+4.4%)
Sep 2016
-
-$1.01B(+3.8%)
Jun 2016
-
-$974.78M(+4.3%)
Mar 2016
-
-$934.50M(+2.1%)
Dec 2015
-$915.23M(+10.8%)
-$915.23M(+3.3%)
Sep 2015
-
-$885.92M(+4.0%)
Jun 2015
-
-$851.48M(+2.9%)
Mar 2015
-
-$827.50M(+0.1%)
Dec 2014
-$826.30M(+7.9%)
-$826.30M(+2.4%)
Sep 2014
-
-$806.86M(+2.0%)
Jun 2014
-
-$790.99M(+1.7%)
Mar 2014
-
-$777.61M(+1.5%)
Dec 2013
-$765.76M(+6.4%)
-$765.76M(+1.4%)
Sep 2013
-
-$755.12M(+1.5%)
Jun 2013
-
-$743.99M(+1.7%)
Mar 2013
-
-$731.75M(+1.7%)
Dec 2012
-$719.67M(-0.7%)
-$719.67M(-1.3%)
Sep 2012
-
-$729.16M(+0.4%)
Jun 2012
-
-$726.09M(+0.1%)
Mar 2012
-
-$725.58M(+0.1%)
Dec 2011
-$724.70M(-4.9%)
-$724.70M(-0.2%)
Sep 2011
-
-$726.03M(-4.1%)
Jun 2011
-
-$757.41M(-0.3%)
Mar 2011
-
-$759.39M(-0.4%)
Dec 2010
-$762.27M
-$762.27M(-0.3%)
DateAnnualQuarterly
Sep 2010
-
-$764.76M(-0.4%)
Jun 2010
-
-$768.09M(+0.7%)
Mar 2010
-
-$762.94M(+1.1%)
Dec 2009
-$754.30M(+7.3%)
-$754.30M(+1.1%)
Sep 2009
-
-$746.38M(+1.1%)
Jun 2009
-
-$738.21M(+2.1%)
Mar 2009
-
-$722.93M(+2.8%)
Dec 2008
-$703.26M(+14.4%)
-$703.26M(+4.3%)
Sep 2008
-
-$674.41M(+2.7%)
Jun 2008
-
-$656.70M(+3.3%)
Mar 2008
-
-$635.73M(+3.4%)
Dec 2007
-$614.65M(+50.9%)
-$614.65M(+26.3%)
Sep 2007
-
-$486.68M(+5.9%)
Jun 2007
-
-$459.44M(+6.1%)
Mar 2007
-
-$433.07M(+6.3%)
Dec 2006
-$407.35M(+35.7%)
-$407.35M(+3.7%)
Sep 2006
-
-$392.64M(+11.1%)
Jun 2006
-
-$353.50M(+8.4%)
Mar 2006
-
-$326.05M(+8.6%)
Dec 2005
-$300.15M(+8.0%)
-$300.15M(+8.7%)
Sep 2005
-
-$276.24M(-8.6%)
Jun 2005
-
-$302.39M(+1.9%)
Mar 2005
-
-$296.79M(+6.8%)
Dec 2004
-$277.95M(+19.7%)
-$277.95M(+8.0%)
Sep 2004
-
-$257.34M(+0.6%)
Jun 2004
-
-$255.69M(+4.6%)
Mar 2004
-
-$244.56M(+5.3%)
Dec 2003
-$232.18M(+15.0%)
-$232.18M(-1.4%)
Sep 2003
-
-$235.38M(+4.4%)
Jun 2003
-
-$225.54M(+4.7%)
Mar 2003
-
-$215.32M(+6.6%)
Dec 2002
-$201.93M(+88.0%)
-$201.93M(+23.8%)
Sep 2002
-
-$163.14M(+14.2%)
Jun 2002
-
-$142.91M(+16.0%)
Mar 2002
-
-$123.15M(+14.7%)
Dec 2001
-$107.39M(+52.4%)
-$107.39M(+15.7%)
Sep 2001
-
-$92.78M(-2.6%)
Jun 2001
-
-$95.29M(+16.3%)
Mar 2001
-
-$81.94M(+16.3%)
Dec 2000
-$70.48M(+69.0%)
-$70.48M(+15.5%)
Sep 2000
-
-$61.05M(+15.4%)
Jun 2000
-
-$52.91M(+10.9%)
Mar 2000
-
-$47.72M(+14.4%)
Dec 1999
-$41.70M(+67.5%)
-$41.70M(+9.7%)
Sep 1999
-
-$38.00M(+13.4%)
Jun 1999
-
-$33.50M(+15.9%)
Mar 1999
-
-$28.90M(+16.1%)
Dec 1998
-$24.90M(+408.2%)
-$24.90M(+37.6%)
Sep 1998
-
-$18.10M(+28.4%)
Jun 1998
-
-$14.10M(+131.1%)
Mar 1998
-
-$6.10M(+24.5%)
Dec 1997
-$4.90M(-51.0%)
-$4.90M(-2.0%)
Sep 1997
-
-$5.00M(-13.8%)
Jun 1997
-
-$5.80M(-1.7%)
Mar 1997
-
-$5.90M(-41.0%)
Dec 1996
-$10.00M
-$10.00M(-31.0%)
Sep 1996
-
-$14.50M(+2.8%)
Jun 1996
-
-$14.10M(-11.3%)
Mar 1996
-
-$15.90M

FAQ

  • What is Neurocrine Biosciences annual retained earnings?
  • What is the all time high annual retained earnings for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual retained earnings year-on-year change?
  • What is Neurocrine Biosciences quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly retained earnings year-on-year change?

What is Neurocrine Biosciences annual retained earnings?

The current annual retained earnings of NBIX is $29.20M

What is the all time high annual retained earnings for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual retained earnings is $29.20M

What is Neurocrine Biosciences annual retained earnings year-on-year change?

Over the past year, NBIX annual retained earnings has changed by +$186.30M (+118.59%)

What is Neurocrine Biosciences quarterly retained earnings?

The current quarterly retained earnings of NBIX is -$5.30M

What is the all time high quarterly retained earnings for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly retained earnings is $81.10M

What is Neurocrine Biosciences quarterly retained earnings year-on-year change?

Over the past year, NBIX quarterly retained earnings has changed by +$108.40M (+95.34%)
On this page